Home RxNorm 1010696 carbinoxamine maleate 0.8 MG/ML Oral Solution Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1010696
RxNorm name carbinoxamine maleate 0.8 MG/ML Oral Solution
Display name Carbinoxamine (Oral Liquid)
Full name carbinoxamine maleate 0.8 MG/ML Oral Solution
Term type SCD
Status Active
Strength 4 mg/5ml
Dose form Sol
Route Oral Liquid
Updated 2026-06-13 07:07:18 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 102010
Active start 102010
Multiple ingredient NO
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength carbinoxamine maleate 0.8 MG / 1 ML carbinoxamine carbinoxamine maleate
Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 64950-243-04 64950-243 Carbinoxamine Maleate Carbinoxamine Maleate Genus Lifesciences Inc. ANDA040458 64950-243-16 64950-243 Carbinoxamine Maleate Carbinoxamine Maleate Genus Lifesciences Inc. ANDA040458
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler ANDA040458 64950-243 Carbinoxamine Maleate Carbinoxamine Maleate ANDA Genus Lifesciences Inc.
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 33 matching rows.
NDC11, Source, Active table NDC11 Source Active 51991033404 rxnav_ndcs yes 51991033416 rxnav_ndcs yes 64950024304 rxnav_ndcs yes 64950024316 rxnav_ndcs yes 00525675204 rxnav_historical_indirect 00525675216 rxnav_historical_indirect 00525675230 rxnav_historical_indirect 15310011001 rxnav_historical 15310011004 rxnav_historical 18011067516 rxnav_historical 46672064101 rxnav_historical 46672064104 rxnav_historical 46672064116 rxnav_historical 46672064404 rxnav_historical 46672064416 rxnav_historical 51301018015 rxnav_historical_indirect 51301018016 rxnav_historical_indirect 51991022801 rxnav_historical_indirect 51991022816 rxnav_historical 54868501900 rxnav_historical 55654003716 rxnav_historical 55654004640 rxnav_historical 58716041216 rxnav_historical 58716041240 rxnav_historical 59702004004 rxnav_historical_indirect 62022025415 rxnav_historical 62022025416 rxnav_historical_indirect 64376061216 rxnav_historical 64376061240 rxnav_historical 64376070416 rxnav_historical 64376071940 rxnav_historical 66239019216 rxnav_historical_indirect 71085008007 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 9d11b197-cfdc-4b9b-9935-2920ccb6e522 carbinoxamine maleate 4 MG in 5 mL Oral Solution [PSN] · carbinoxamine maleate 0.8 MG/ML Oral Solution [SCD] · carbinoxamine maleate 0.8 MG/ML Oral Syrup [SY] · carbinoxamine maleate 4 MG per 5 ML Oral Solution [SY] 4 6 Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL 20240306 a845fc15-c675-4e33-840c-6a74e79d0ced carbinoxamine maleate 4 MG in 5 mL Oral Solution [PSN] · carbinoxamine maleate 0.8 MG/ML Oral Solution [SCD] · carbinoxamine maleate 0.8 MG/ML Oral Syrup [SY] · carbinoxamine maleate 4 MG per 5 ML Oral Solution [SY] 4 3 CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL 20250616
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective a845fc15-c675-4e33-840c-6a74e79d0ced CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL IPG Pharmaceuticals, inc. 20250616 9d11b197-cfdc-4b9b-9935-2920ccb6e522 Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL Genus Lifesciences Inc. | Mikart 20240306 1edca669-8879-408a-b09c-259e363dd95c Breckenridge Pharmaceutical, Inc. 20220923 748c233b-6ab9-42d0-89ab-e7ead30f7947 Mikart, LLC 20200521 e7d4b2a4-2dae-4026-a381-9d534d36c6b3 Mikart, LLC 20200408 1741b4f2-af49-43fe-8319-7b8a38fa25d2 Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL Rx Only Par Pharmaceutical, Inc. | Sovereign Pharmaceuticals, LLC 20180314 018249a0-b3b6-4821-a532-c4fbca3d4f1e National Council for Prescription Drug Programs 20130401 0d52a3ae-f954-4a7c-8828-a11853d4b750 National Council for Prescription Drug Programs 20130401 16096a5b-18fe-42ed-9a03-7c43a852c95c National Council for Prescription Drug Programs 20120724 20252c7c-7022-40b6-9f1d-927c338fd932 National Council for Prescription Drug Programs 20120724 48561025-bdd5-49dc-8aa2-b3442bb9dcf9 National Council for Prescription Drug Programs 20120724 aca6edb0-5899-44af-8d20-f37176f5ecff National Council for Prescription Drug Programs 20120724
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC R06AA Aminoalkyl ethers ATC1-4 carbinoxamine FDASPL N0000175587 Histamine-1 Receptor Antagonist EPC has_epc carbinoxamine FDASPL N0000000190 Histamine H1 Receptor Antagonists MOA has_moa carbinoxamine MEDRT D011725 Pyridines CHEM has_ingredient carbinoxamine maleate MEDRT D011725 Pyridines CHEM has_ingredient carbinoxamine MEDRT D000799 Angioedema DISEASE may_treat carbinoxamine MEDRT D000799 Angioedema DISEASE may_treat carbinoxamine maleate MEDRT D001942 Breast Feeding DISEASE ci_with carbinoxamine MEDRT D001942 Breast Feeding DISEASE ci_with carbinoxamine maleate MEDRT D003233 Conjunctivitis, Allergic DISEASE may_treat carbinoxamine MEDRT D003233 Conjunctivitis, Allergic DISEASE may_treat carbinoxamine maleate MEDRT D003327 Coronary Disease DISEASE ci_with carbinoxamine maleate MEDRT D003327 Coronary Disease DISEASE ci_with carbinoxamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with carbinoxamine maleate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with carbinoxamine MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with carbinoxamine maleate MEDRT D015812 Glaucoma, Angle-Closure DISEASE ci_with carbinoxamine MEDRT D006973 Hypertension DISEASE ci_with carbinoxamine maleate MEDRT D006973 Hypertension DISEASE ci_with carbinoxamine MEDRT D007231 Infant, Newborn DISEASE ci_with carbinoxamine maleate MEDRT D007231 Infant, Newborn DISEASE ci_with carbinoxamine MEDRT D007234 Infant, Premature DISEASE ci_with carbinoxamine maleate MEDRT D007234 Infant, Premature DISEASE ci_with carbinoxamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with carbinoxamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with carbinoxamine maleate MEDRT D010437 Peptic Ulcer DISEASE ci_with carbinoxamine MEDRT D010437 Peptic Ulcer DISEASE ci_with carbinoxamine maleate MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat carbinoxamine MEDRT D012221 Rhinitis, Allergic, Perennial DISEASE may_treat carbinoxamine maleate MEDRT D012223 Rhinitis, Vasomotor DISEASE may_treat carbinoxamine MEDRT D012223 Rhinitis, Vasomotor DISEASE may_treat carbinoxamine maleate MEDRT D013224 Status Asthmaticus DISEASE ci_with carbinoxamine MEDRT D013224 Status Asthmaticus DISEASE ci_with carbinoxamine maleate MEDRT D014517 Ureteral Obstruction DISEASE ci_with carbinoxamine MEDRT D014517 Ureteral Obstruction DISEASE ci_with carbinoxamine maleate MEDRT D014524 Urethral Obstruction DISEASE ci_with carbinoxamine MEDRT D014524 Urethral Obstruction DISEASE ci_with carbinoxamine maleate MEDRT N0000000190 Histamine H1 Receptor Antagonists MOA has_moa carbinoxamine MEDRT N0000000190 Histamine H1 Receptor Antagonists MOA has_moa carbinoxamine maleate MEDRT N0000000184 Monoamine Oxidase Inhibitors MOA ci_moa carbinoxamine MEDRT N0000000184 Monoamine Oxidase Inhibitors MOA ci_moa carbinoxamine maleate MEDRT N0000008657 Decreased Histamine Activity PE has_pe carbinoxamine MEDRT N0000008657 Decreased Histamine Activity PE has_pe carbinoxamine maleate
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.8 MG/ML ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES ANDA ANDA040458 CODES SNOMEDCT 409192006 CODES VUID 4032213 CODES VUID 4032214 NAMES Prescribable Synonym carbinoxamine maleate 4 MG in 5 mL Oral Solution SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon SOURCES Source National Drug Data File Plus Source Vocabulary SOURCES Source US Edition of SNOMED_CT SOURCES Source Veterans Health Administration National Drug File